Packaging and Labeling in the Pharmaceutical Supply Chain
Completion of this webinar, you will be able to:Avoid unnecessary production costs, back orders and recalls, especially during product launches, As a result, it is essential to include Packaging and Labeling in the initial stages of product and package development to avoid issues during production.
Wednesday, May 26, 2021
10:00 AM PDT | 01:00 PM EDT
More Trainings by this Expert
Product Id : 503793
Live: One Dial-in One Attendee
Corporate Live: Any number of participants
Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Packaging and Labeling form a bridge between the conception of a product and its realization and distribution, and consequently occupy a critical position in the success or failure of any pharmaceutical product launch or revision.
Decision-makers need at least a cursory knowledge of potential pitfalls to create contingencies, as it is easier and more cost-effective to change things earlier in process than later.
The importance of Packaging and Labeling is often underestimated, especially in the planning phases, and as Packaging and Labeling tasks occur closer to the end of a product launch or revision, excess time is often spent in the earlier phases of product development and encroaches on these activities.
In addition, the types and numbers of errors that are possible at the packaging and labeling stages are greater than many people realize, and these errors in can lead to unnecessary increases in cycle time or cost, delays in product availability possibly leading to reduced sales, or product recalls due to noncompliance.
As a result, it is essential to include Packaging and Labeling in the initial stages of product and package development to avoid issues during production.
Why you should Attend:
Packaging and Labeling occupy a critical position in the success or failure of any product launch and in the production of pharmaceuticals in general because they impact many company functions. Their activities also are crucial for compliance with regulatory agency requirements.
Still, their criticality is often underestimated especially in the planning phases, leading to unnecessary increases in cycle time, costly errors and delays in product availability. Your understanding of its importance as it relates to your own deliverables will provide you an advantage in achieving success.
Upon completion of this webinar, you’ll be able to:
Areas Covered in the Session:
- Articulate Packaging and Labeling's role in product development
- Ensure adherence to regulatory agency requirements
- Anticipate potential obstacles in marketing, medical affairs, regulatory, legal or quality assurance
- Work effectively with contract manufacturers or packagers
- Manage labeling in foreign languages
- Avoid unnecessary production costs, back orders and recalls, especially during product launches
Who Will Benefit:
- Regulatory requirements
- Combination packages
- Packaging and labeling stakeholders
- Packaging and labeling's role in product creation or revision
- Printed packaging workflow
- Elements of packaging (e.g. numbers, codes)
- Packaging component types
- Packaging and labeling errors to avoid
- Supply chain issues
- Special circumstances affecting packaging and labeling activities
- Obstacles that can be overcome
- Marketing Product Managers
- Project Managers
- Operations Coordinators or Managers
- Regulatory Affairs Managers
- Labeling and Packaging professionals at all levels
- Quality Assurance Specialists or Managers Production Control
Michael Esposito has over 30 years experience in the pharmaceutical industry and 17 years experience in GMP training and document management. He has worked for Wyeth Pharmaceuticals, Pfizer and Johnson & Johnson's McNeil Consumer Healthcare Division in a variety of areas including Packaging, project administration, Quality Assurance, Government Contracts, translations, systems training, and international operations.
He collaborated in the development and implementation of the training portion of the Consent Decree workplan for McNeil and revised their introductory GMP course. He is a member of the training organizations GMP Training Educators Association and Association for GXP Excellence (AGXPE) and is fully fluent in Spanish. His areas of interest include systems training, training effectiveness, post-training user support, process improvement, and sustainable packaging.